UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000035918 |
|---|---|
| Receipt number | R000040920 |
| Scientific Title | Verification of blood lactate acid as index of muscle fatigue recovery |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2019/02/18 17:32:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Verification of blood lactate acid as index of muscle fatigue recovery
Acronym
Validity of blood lactate acid
Scientific Title
Verification of blood lactate acid as index of muscle fatigue recovery
Scientific Title:Acronym
Validity of blood lactate acid
Region
| Japan |
Condition
Condition
healthy adults
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In this study, an effective procedure for stretching and citric acid intake, which is used as a method of muscle fatigue restoration, will be studied with the blood lactate value as an index of effect determination.
Basic objectives2
Others
Basic objectives -Others
In this study, an effective procedure for stretching and citric acid intake, which is used as a method of muscle fatigue restoration, will be studied with the blood lactate value as an index of effect determination. As a result of this study, if the effective implementation contents of stretching and citric acid intake are clarified, there is a possibility that in the clinical practice of physical therapy, more appropriate support including not only exercise but also recovery of muscle fatigue by exercise is possible is there.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Changes in blood lactate acid before and after intervention
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -participants are blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food | Other |
Interventions/Control_1
Presence / absence of stretching,
Interventions/Control_2
timing of ingestion of citric acid
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 50 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. Adult (both male and female are acceptable). It also covers Shinshu University and hospital officials, students, and those belonging to the medical department.
2. Person who got written consent based on his her free will after receiving sufficient explanation for participation in this research
Key exclusion criteria
1.Person who regularly ingests ascorbic acid, supplement containing L-cysteine.
2. Pregnant women.
3. Person who is administered a biguanite agent.
4. Persons undergoing confirmed diagnosis of lactic acidosis.
5. In addition, patients whose research managers judged inappropriate as subjects
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hitomi Nishizawa |
Organization
Shinshu University
Division name
School of Medicine Department of Health Sciences
Zip code
Address
3-1-1 Asahi Matsumoto City, Nagano Prefecture
TEL
0263-37-2414
hitnishi@shinshu-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hitomi Nishizawa |
Organization
Shinshu University
Division name
School of Medicine Department of Health Sciences
Zip code
Address
3-1-1 Asahi Matsumoto City, Nagano Prefecture
TEL
0263-37-2414
Homepage URL
hitnishi@shinshu-u.ac.jp
Sponsor or person
Institute
Shinshu University
Institute
Department
Personal name
Funding Source
Organization
Shinshu University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
YES
Study ID_1
nishiza-748
Org. issuing International ID_1
Shinshu University
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2019 | Year | 02 | Month | 04 | Day |
Date of IRB
Anticipated trial start date
| 2019 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2019 | Year | 02 | Month | 18 | Day |
Last modified on
| 2019 | Year | 02 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040920
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
